AusPAR: Nivolumab

Australian Public Assessment Report

AusPAR

AusPAR: Nivolumab [PDF, 2.76 MB]

AusPAR: Nivolumab [Word, 5.17 MB]

Attachment: Product Information for Nivolumab [PDF, 1.29 MB]

Attachment: Product Information for Nivolumab [Word, 3.07 MB]

Device/Product Name

Opdivo

Active ingredients

Nivolumab

AusPAR Date

24 January 2020

Published

12 February 2020

Submission Number

PM-2017-02209-1-4

Submission Type

Major variation (new indication)

Decision

Approved